全文获取类型
收费全文 | 28314篇 |
免费 | 2881篇 |
国内免费 | 111篇 |
专业分类
耳鼻咽喉 | 325篇 |
儿科学 | 943篇 |
妇产科学 | 535篇 |
基础医学 | 3745篇 |
口腔科学 | 592篇 |
临床医学 | 3382篇 |
内科学 | 5056篇 |
皮肤病学 | 319篇 |
神经病学 | 2928篇 |
特种医学 | 1239篇 |
外科学 | 4288篇 |
综合类 | 709篇 |
一般理论 | 5篇 |
预防医学 | 3041篇 |
眼科学 | 540篇 |
药学 | 1753篇 |
2篇 | |
中国医学 | 12篇 |
肿瘤学 | 1892篇 |
出版年
2021年 | 362篇 |
2020年 | 229篇 |
2019年 | 411篇 |
2018年 | 517篇 |
2017年 | 361篇 |
2016年 | 363篇 |
2015年 | 450篇 |
2014年 | 619篇 |
2013年 | 1000篇 |
2012年 | 1349篇 |
2011年 | 1307篇 |
2010年 | 775篇 |
2009年 | 762篇 |
2008年 | 1240篇 |
2007年 | 1247篇 |
2006年 | 1186篇 |
2005年 | 1106篇 |
2004年 | 1117篇 |
2003年 | 1055篇 |
2002年 | 922篇 |
2001年 | 919篇 |
2000年 | 948篇 |
1999年 | 764篇 |
1998年 | 440篇 |
1997年 | 421篇 |
1996年 | 417篇 |
1995年 | 377篇 |
1994年 | 353篇 |
1993年 | 368篇 |
1992年 | 664篇 |
1991年 | 654篇 |
1990年 | 624篇 |
1989年 | 649篇 |
1988年 | 604篇 |
1987年 | 622篇 |
1986年 | 561篇 |
1985年 | 561篇 |
1984年 | 417篇 |
1983年 | 356篇 |
1982年 | 257篇 |
1981年 | 231篇 |
1980年 | 222篇 |
1979年 | 366篇 |
1978年 | 208篇 |
1977年 | 217篇 |
1976年 | 247篇 |
1975年 | 195篇 |
1974年 | 240篇 |
1973年 | 228篇 |
1972年 | 187篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
992.
993.
994.
995.
996.
James Cleary Henry Ddungu Sandra R. Distelhorst Carla Ripamonti Gary M. Rodin Mohammad A. Bushnaq Joe N. Clegg-Lamptey Stephen R. Connor Msemo B. Diwani Alexandru Eniu Joe B. Harford Suresh Kumar M.R. Rajagopal Beti Thompson Julie R. Gralow Benjamin O. Anderson 《Breast (Edinburgh, Scotland)》2013,22(5):616-627
Many women diagnosed with breast cancer in low- and middle-income countries (LMICs) present with advanced-stage disease. While cure is not a realistic outcome, site-specific interventions, supportive care, and palliative care can achieve meaningful outcomes and improve quality of life.As part of the 5th Breast Health Global Initiative (BHGI) Global Summit, an expert international panel identified thirteen key resource recommendations for supportive and palliative care for metastatic breast cancer. The recommendations are presented in three resource-stratified tables: health system resource allocations, resource allocations for organ-based metastatic breast cancer, and resource allocations for palliative care. These tables illustrate how health systems can provide supportive and palliative care services for patients at a basic level of available resources, and incrementally add services as more resources become available.The health systems table includes health professional education, patient and family education, palliative care models, and diagnostic testing. The metastatic disease management table provides recommendations for supportive care for bone, brain, liver, lung, and skin metastases as well as bowel obstruction. The third table includes the palliative care recommendations: pain management, and psychosocial and spiritual aspects of care.The panel considered pain management a priority at a basic level of resource allocation and emphasized the need for morphine to be easily available in LMICs. Regular pain assessments and the proper use of pharmacologic and non-pharmacologic interventions are recommended. Basic-level resources for psychosocial and spiritual aspects of care include health professional and patient and family education, as well as patient support, including community-based peer support. 相似文献
997.
Apostolos Apostolidis Catherine Thompson Xiaohong Yan Sherif Mourad 《World journal of urology》2013,31(6):1469-1474
Purpose
To explore the dose response to onabotulinumtoxinA 50, 100, and 200 U in patients with spinal cord injury (SCI) with urinary incontinence (UI) due to neurogenic detrusor overactivity (NDO).Methods
Patients (N = 73) with SCI (level T1 or lower) with NDO and UI (≥14 UI episodes/week) received 30 intradetrusor injections of onabotulinumtoxinA (50 U [n = 19], 100 U [n = 21], or 200 U [n = 17]) or placebo (n = 16) via cystoscopy, avoiding the trigone. Changes from baseline in UI episodes/week, volume voided/micturition, maximum cystometric capacity, and maximum detrusor pressure (MDP) during first involuntary detrusor contraction (IDC) were evaluated. Adverse events (AEs) were assessed.Results
A significant linear dose response for UI episodes/week was identified at weeks 18, 30, 36, 42, and 54 (P < 0.05) with a similar trend (P = 0.092) at week 6 (primary time point). A significant linear dose response was observed in volume/void at all post-treatment time points up to week 54 (P < 0.05) and in MDP during first IDC at week 6 (P = 0.034). The proportion of patients who achieved continence at week 6 was highest in the 200 U group. Duration of effect was longest with the 200 U dose, compared with other treatment groups. The AEs were comparable across groups; urinary tract infection was the most common AE across all treatment groups.Conclusions
In this exploratory dose–response study of SCI patients with UI due to NDO, onabotulinumtoxinA 200 U was the most effective dose. The AE profile was comparable across all groups. 相似文献998.
999.
Evangeline L. McDonald C. Lamonte Powell Jennie P. Perryman Nancy J. Thompson Kimberly R. Jacob Arriola 《Clinical transplantation》2013,27(4):619-626
Transplantation is the favored therapy for patients with end‐stage renal disease (ESRD). Unfortunately, demand for available organs far outpaces the supply. African Americans are disproportionately affected by the ever‐widening gap between organ supply and demand. Additionally, structural, biological, and social factors contribute to feelings of unease some African Americans may feel regarding living donor transplant (LDT). The present research examines the relationship between trust in health care and attitudes toward LDT among African American ESRD patients. We hypothesized that lower trust in health care would be significantly associated with negative attitudes toward LDT, and that this relationship would be moderated by patient attitudes toward dialysis. Data were collected from August 2011 to April 2012 as part of a larger study. Measures included trust (of doctors, racial equity of treatment, and hospitals) and attitudes toward both LDT and dialysis. Bivariate analysis revealed that trust in one's doctor, hospital, and in racial equity in health care was significantly correlated with attitudes toward LDT (r = 0.265; r = 0.131; and r = 0.202, respectively). Additionally, attitudes toward dialysis moderated the relationships between Trust in Doctors/Attitudes toward LDT and Trust in Racial equity of treatment/Attitudes toward LDT. Findings suggest a strong relationship between trust in health care and attitudes toward LDT. These findings also shed light on how dialysis experiences are related to the relationship between trust in health care and attitudes toward LDT. 相似文献
1000.
Scott Worley MD BScPT Jeff Pike MD David Anderson MD Jo-Anne Douglas BSc Kara Thompson BSc MSc 《The journal of spinal cord medicine》2013,36(4):379-387
Background: When venous thromboembolism (VTE) includes deep-vein thrombosis (DVT) and pulmonary embolism (PE), patients with acute traumatic spinal cord injury (SCI) have the highest incidence of VTE among all hospitalized groups, with PE the third most common cause of death. Although low-molecular-weight heparin (LMWH) outperforms low-dose unfractionated heparin (LDUH) in other patient populations, the evidence in SCI remains less robust.Objective: To determine whether the efficacy for LMWH shown in previous SCI surveillance studies (eg, routine Doppler ultrasound) would translate into real-world effectiveness in which only clinically evident VTE is investigated (ie, after symptoms or signs present).Methods: A retrospective cohort study was conducted of 90 patients receiving LMWH dalteparin (5,000 U daily) or LDUH (5,000 U twice daily) for VTE prophylaxis after acute traumatic SCI. The incidence of radiographically confirmed VTE was primarily analyzed, and secondary outcomes included complications of bleeding and heparin-induced thrombocytopenia.Results: There was no statistically significant association (p = 0.7054) between the incidence of VTE (7.78% overall) and the type of prophylaxis received (LDUH 3/47 vs dalteparin 4/43). There was no significant differences in complications, location of VTE, and incidence of fatal PE. Paraplegia (as opposed to tetraplegia) was the only risk factor identified for VTE.Conclusions: There continues to be an absence of definitive evidence for dalteparin (or other LMWH) over LDUH as the choice for VTE prophylaxis in patients with SCI. Novel approaches to VTE prophylaxis are urgently required for this population, whose risk of fatal PE has not decreased over the last 25 years. 相似文献